Seeking Alpha

Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 35 years executive experience including Abbott and JNJ and has been involved three successful start-ups. Before starting Raygent and other companies he was also a... More
My company:
Raygent Capital
My blog:
Raygent.com,Rayno Life Science
  • Stealth Sell-Off In Biotech Stocks 0 comments
    Feb 15, 2014 7:25 PM | about stocks: BIIB, IBB, XBI

    Update After Friday Close:

    IBB up 4.5% for Week, XBI up 3.9% But stocks sell off Friday AM after hitting new highs.

    Major losers among mid caps on 2/14 were: PBYI, PCYC, VRTX down about 4%; ALNY, CBST, INCY, MDVN, NBIX, SGEN and XBI down about 2-3%. Watch potential double top in XBI near term.This is a good time to look at your life science portfolio and take profits to 15% cash.

    Biogen Names Papadopoulos Chairman

    ------------

    Profit Taking On High Fliers- INCY, MDVN, PBYI, XBI

    Agilent(NYSE:A) Growth Slows

    NASDAQ Flat at 4234 12:15p EST

    After hitting new highs this week biotech stocks are in a wave of selling so watch technicals and volume. The small cap, speculative weighted XBI ETF is down 1.81 % after an early reversal off AM Valentine's Day highs. The "equal weight" holdings gets re-balanced quickly but many of the XBI stocks are down this week and today: ALNY, GALE, ICPT, NVAX, PBYI, SGMO etc. -see detailed holdings. The IBB is much less volatile than the XBI due to more concentrated holdings of large caps.

    There is a lot of red within the Rayno Biopharmaceutical Portfolio such as : ALKS down 2%, CBST down 1.9%, GILD down 2.2%, PCYC down 2.9% and SGEN down 3%. BIIB is stable up 0.34%.

    Most mid and small cap biopharma stocks in our index are red except ACHN, ARIA , GERN and THRX.

    In the tools/diagnostics sector and possibly a bellwether Agilent (A $56) is down 6.7% on slower revenue growth and guidance.

    Earlier this week we urged a life science sector weighting to 15% cash due to huge moves in January.Update after close today.

    Disclosure: I am long ACHN.

    Additional disclosure: Long Fidelity Select Biotech Fund (MUTF:FBIOX) and short individual biopharma stocks on a daily basis.

    Stocks: BIIB, IBB, XBI
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.